ID: ALA5201258

Max Phase: Preclinical

Molecular Formula: C30H47N3O3

Molecular Weight: 497.72

Associated Items:

Representations

Canonical SMILES:  CC(C)CCC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC1[C@]23C=C[C@]2(C[C@@H](O)CC[C@]12C)n1c(=O)n(C)c(=O)n13

Standard InChI:  InChI=1S/C30H47N3O3/c1-19(2)8-7-9-20(3)22-10-11-23-27(22,4)14-13-24-28(5)15-12-21(34)18-29(28)16-17-30(23,24)33-26(36)31(6)25(35)32(29)33/h16-17,19-24,34H,7-15,18H2,1-6H3/t20-,21+,22-,23-,24?,27-,28-,29-,30+/m1/s1

Standard InChI Key:  JSGDDTNEBHLDPF-OSUFGNAPSA-N

Associated Targets(Human)

VDR Tclin Vitamin D receptor (26531 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PPARG Tclin Peroxisome proliferator-activated receptor gamma (15191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 497.72Molecular Weight (Monoisotopic): 497.3617AlogP: 4.78#Rotatable Bonds: 5
Polar Surface Area: 69.16Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 5.52CX LogD: 5.52
Aromatic Rings: 1Heavy Atoms: 36QED Weighted: 0.60Np Likeness Score: 1.73

References

1. Khazan N, Kim KK, Hansen JN, Singh NA, Moore T, Snyder CWA, Pandita R, Strawderman M, Fujihara M, Takamura Y, Jian Y, Battaglia N, Yano N, Teramoto Y, Arnold LA, Hopson R, Kishor K, Nayak S, Ojha D, Sharon A, Ashton JM, Wang J, Milano MT, Miyamoto H, Linehan DC, Gerber SA, Kawar N, Singh AP, Tabdanov ED, Dokholyan NV, Kakuta H, Jurutka PW, Schor NF, Rowswell-Turner RB, Singh RK, Moore RG..  (2022)  Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors In Vivo.,  65  (8.0): [PMID:35404047] [10.1021/acs.jmedchem.1c01878]

Source